Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Jun;66(6):754–758. doi: 10.1136/jnnp.66.6.754

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

K Ito 1, P Morrish 1, J Rakshi 1, T Uema 1, J Ashburner 1, D Bailey 1, K Friston 1, D Brooks 1
PMCID: PMC1736402  PMID: 10329749

Abstract

OBJECTIVE—To apply statistical parametric mapping to 18F-dopa PET data sets, to examine the regional distribution of changes in dopaminergic metabolism in early asymmetric Parkinson's disease.
METHODS—Thirteen normal volunteers (age 57.7 (SD 16.5) years; four women, nine men ) and six patients (age 50.3 (SD 13.5) years; three women, three men) with asymmetric (right sided) Parkinson's disease were studied. Images from each dynamic dopa PET dataset were aligned and parametric images of 18F-dopa influx (Ki) were created for each subject. The Ki images were transformed into standard stereotactic space. The Ki values of the caudate and putamen on spatially normalised images were compared with the Ki values before normalisation. The application of statistical parametric mapping (SPM) allowed statistical comparison of regional Ki values on a voxel by voxel basis between healthy volunteers and patients with Parkinson's disease.
RESULTS—There was a strong correlation between the Ki values before and after spatial normalisation (r=0.898, p=0.0001). Significant decreases in the Ki values were found for the Parkinson's desease group throughout the entire left putamen (p< 0.001) and focally in the dorsal right putamen (p< 0.001). Decreased Ki values were also shown bilaterally in the substantia nigra (p< 0.01).
CONCLUSION—Using (SPM) and 18F-dopa PET, reductions in both striatal and nigral brain dopaminergic function could be demonstrated in early Parkinson's disease.



Full Text

The Full Text of this article is available as a PDF (169.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhatt M. H., Snow B. J., Martin W. R., Pate B. D., Ruth T. J., Calne D. B. Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Ann Neurol. 1991 Jun;29(6):673–677. doi: 10.1002/ana.410290617. [DOI] [PubMed] [Google Scholar]
  2. Brooks D. J. Detection of preclinical Parkinson's disease with PET. Neurology. 1991 May;41(5 Suppl 2):24–28. doi: 10.1212/wnl.41.5_suppl_2.24. [DOI] [PubMed] [Google Scholar]
  3. Brooks D. J., Salmon E. P., Mathias C. J., Quinn N., Leenders K. L., Bannister R., Marsden C. D., Frackowiak R. S. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain. 1990 Oct;113(Pt 5):1539–1552. doi: 10.1093/brain/113.5.1539. [DOI] [PubMed] [Google Scholar]
  4. Burn D. J., Mark M. H., Playford E. D., Maraganore D. M., Zimmerman T. R., Jr, Duvoisin R. C., Harding A. E., Marsden C. D., Brooks D. J. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 1992 Oct;42(10):1894–1900. doi: 10.1212/wnl.42.10.1894. [DOI] [PubMed] [Google Scholar]
  5. Friston K. J., Frith C. D., Liddle P. F., Frackowiak R. S. Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab. 1991 Jul;11(4):690–699. doi: 10.1038/jcbfm.1991.122. [DOI] [PubMed] [Google Scholar]
  6. Friston K. J., Frith C. D., Liddle P. F., Frackowiak R. S. Plastic transformation of PET images. J Comput Assist Tomogr. 1991 Jul-Aug;15(4):634–639. doi: 10.1097/00004728-199107000-00020. [DOI] [PubMed] [Google Scholar]
  7. Gibb W. R., Lees A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745–752. doi: 10.1136/jnnp.51.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guttman M., Burns R. S., Martin W. R., Peppard R. F., Adam M. J., Ruth T. J., Allen G., Parker R. A., Tulipan N. B., Calne D. B. PET studies of parkinsonian patients treated with autologous adrenal implants. Can J Neurol Sci. 1989 Aug;16(3):305–309. doi: 10.1017/s0317167100029139. [DOI] [PubMed] [Google Scholar]
  9. Hoehn M. M., Yahr M. D. Parkinsonism: onset, progression and mortality. Neurology. 1967 May;17(5):427–442. doi: 10.1212/wnl.17.5.427. [DOI] [PubMed] [Google Scholar]
  10. Kish S. J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med. 1988 Apr 7;318(14):876–880. doi: 10.1056/NEJM198804073181402. [DOI] [PubMed] [Google Scholar]
  11. Morrish P. K., Sawle G. V., Brooks D. J. Clinical and [18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):597–600. doi: 10.1136/jnnp.59.6.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morrish P. K., Sawle G. V., Brooks D. J. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain. 1996 Dec;119(Pt 6):2097–2103. doi: 10.1093/brain/119.6.2097. [DOI] [PubMed] [Google Scholar]
  13. Pate B. D., Snow B. J., Hewitt K. A., Morrison K. S., Ruth T. J., Calne D. B. The reproducibility of striatal uptake data obtained with positron emission tomography and fluorine-18-L-6-fluorodopa tracer in non-human primates. J Nucl Med. 1991 Jun;32(6):1246–1251. [PubMed] [Google Scholar]
  14. Patlak C. S., Blasberg R. G., Fenstermacher J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983 Mar;3(1):1–7. doi: 10.1038/jcbfm.1983.1. [DOI] [PubMed] [Google Scholar]
  15. Patlak C. S., Blasberg R. G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 1985 Dec;5(4):584–590. doi: 10.1038/jcbfm.1985.87. [DOI] [PubMed] [Google Scholar]
  16. Sawle G. V., Bloomfield P. M., Björklund A., Brooks D. J., Brundin P., Leenders K. L., Lindvall O., Marsden C. D., Rehncrona S., Widner H. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol. 1992 Feb;31(2):166–173. doi: 10.1002/ana.410310207. [DOI] [PubMed] [Google Scholar]
  17. Sawle G. V., Wroe S. J., Lees A. J., Brooks D. J., Frackowiak R. S. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred. Ann Neurol. 1992 Nov;32(5):609–617. doi: 10.1002/ana.410320503. [DOI] [PubMed] [Google Scholar]
  18. Vingerhoets F. J., Schulzer M., Ruth T. J., Holden J. E., Snow B. J. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease. J Nucl Med. 1996 Mar;37(3):421–426. [PubMed] [Google Scholar]
  19. Vingerhoets F. J., Snow B. J., Schulzer M., Morrison S., Ruth T. J., Holden J. E., Cooper S., Calne D. B. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med. 1994 Jan;35(1):18–24. [PubMed] [Google Scholar]
  20. Woods R. P., Cherry S. R., Mazziotta J. C. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992 Jul-Aug;16(4):620–633. doi: 10.1097/00004728-199207000-00024. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES